Cytomegalovirus Vaccine in Healthy Participants

Phase 1 Completed 46 enrolled City of Hope Medical Center National Cancer Institute (NCI) · collab

RandomizedDouble-blindTreatment

Summary

RATIONALE: Vaccines may help the body build an effective immune response against cytomegalovirus. PURPOSE: This randomized phase I trial is studying the side effects and best dose of cytomegalovirus vaccine in healthy participants.

Timeline

Start: 1997-11
Primary completion: 2009-04
Completion: 2009-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CMVpp65-A*0201 peptide vaccine	Vaccine	—	Subcutaneous

Cytomegalovirus Vaccine in Healthy Participants

Summary

Timeline

Drugs

Indications